MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-DL-10-0041187
Optimum Therapeutics Private Limited - healthcare in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹23.73 Cr
▲ 16% YoY
Net profit · FY 2024
₹1.74 Cr
Net margin 7.3%
EBITDA · FY 2024
₹3.32 Cr
EBITDA margin 14%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹3.3 Cr
Secured borrowings
Company age
15 yrs
Est. 2011
Directors on board
2
As per MCA filings
About Optimum Therapeutics Private Limited
Data last updated:
Optimum Therapeutics Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the oncology clinics and cancer treatment segment of the healthcare sector. It was incorporated on 13 December 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U85100DL2011PTC228675. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Sharmin Yaqin and Jamal Anono Khan.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Flat No 1A Ground Floor 18 Poorvi Marg Vasant Vihar New Delhi, Delhi, India – 110057.
As per the financials filed for FY 2024, the company reported a revenue of ₹23.73 Cr, a growth of 16% compared to the previous year. For the same year it recorded a net profit of ₹1.74 Cr (net margin 7.3%) and EBITDA of ₹3.32 Cr (EBITDA margin 14%). Revenue has grown at a compounded annual rate (CAGR) of 15% over three years and 16% over five years.
The company is associated with 2 brands: Denvax and Optimum Therapeutics. As per MCA filings, the company has open charges of ₹3.3 Cr on record. Court records list 5 cases involving the company, including 2 filed by the company and 3 filed against it; 2 cases are pending.
Optimum Therapeutics Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-10-0041187). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website denvaxindia.com.
Company Details of Optimum Therapeutics Private Limited
CIN U85100DL2011PTC228675
Registration Number 228675
Incorporation Date 13 December 2011
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-DL-10-0041187
Key People
Sharmin Yaqin Director Jamal Anono Khan Director Recognitions & Rankings of Optimum Therapeutics
Contact Details
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressFlat No 1A Ground Floor 18 Poorvi Marg Vasant Vihar New Delhi, Delhi, India – 110057
- IndustryHealthcare, Oncology Clinics & Cancer Treatment
Comprehensive company report
Optimum Therapeutics Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Associated Brands with Optimum Therapeutics Private Limited
Optimum Therapeutics operates two associated brands: Denvax and Optimum Therapeutics. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Operates a dedicated hospital specializing in cancer care and treatment. | denvaxindia.com | |
| Tumor-selective therapeutics are discovered and developed for solid tumors. | optimumtx.com |
Business Activity of Optimum Therapeutics Private Limited
The main business activity of Optimum Therapeutics is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Optimum Therapeutics Private Limited FY 2025 filings available
Optimum Therapeutics Private Limited reported revenue of ₹23.73 Cr (up 16% YoY) for FY 2024.
Revenue · FY 2024
₹23.73 Cr ▲ 16%
Net profit · FY 2024
₹1.74 Cr margin 7.3%
EBITDA · FY 2024
₹3.32 Cr margin 14%
Compounded Annual Growth Rate (CAGR) of Optimum Therapeutics Private Limited
Revenue CAGR growth
1 year
▲ 16%
3 years · compounded
▲ 15%
5 years · compounded
▲ 16%
EBITDA CAGR growth
1 year
▲ 7%
3 years · compounded
▲ 15%
5 years · compounded
▲ 14%
Revenue has grown at a compounded annual rate (CAGR) of 16% over five years, including 16% growth in the latest year. EBITDA rose 7% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Optimum Therapeutics Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹3.32 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹1.74 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Optimum Therapeutics Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 14% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 7.3% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Optimum Therapeutics are in the company report.
Premium access
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Optimum Therapeutics Private Limited
Optimum Therapeutics has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sharmin Yaqin | Director | 13 Dec 2011 | 14 Years 10 Months | Current |
| Jamal Anono Khan | Director | 13 Dec 2011 | 14 Years 10 Months | Current |
Peer Comparison of Optimum Therapeutics Private Limited
Optimum Therapeutics Private Limited is compared with the companies closest to it by revenue in the Healthcare industry (Oncology Care). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Carcinova Private Limited | ₹37.02 Cr (FY 2025) | •••• | •••• | 44.0% | •••• | Cuttack, Odisha, India |
| Cancer Centers of America Private Limited | ₹36.39 Cr (FY 2025) | •••• | •••• | 61.0% | •••• | Hyderabad, Telangana, India |
| Suprex Healthcare Private Limited | ₹32.94 Cr (FY 2025) | •••• | •••• | 41.0% | •••• | Delhi, India |
| Buddha Cancer Centre Private Limited | ₹32.36 Cr (FY 2025) | •••• | •••• | 46.0% | •••• | Asian School, Danapur, Bihar, India |
| Oncocare Medicals Private Limited | ₹26.55 Cr (FY 2025) | •••• | •••• | 2.0% | •••• | Kanpur, Uttar Pradesh, India |
| Optimum Therapeutics Private Limited this company | ₹23.73 Cr (FY 2024) | •••• | •••• | 16.0% | •••• | New Delhi, Delhi, India |
| Starlit Hospitals Private Limited | ₹23.2 Cr (FY 2025) | •••• | •••• | 12.0% | •••• | Ahmedabad, Gujarat, India |
| Amrish Oncology Services Private Limited | ₹22.22 Cr (FY 2025) | •••• | •••• | -56.0% | •••• | Ahmedabad, Gujarat, India |
| Oncoville Private Limited | ₹21.99 Cr (FY 2024) | •••• | •••• | 62.0% | •••• | Bengaluru, Karnataka, India |
| Sunact Cancer Institute Private Limited | ₹21.19 Cr (FY 2025) | •••• | •••• | 34640.0% | •••• | Thane, Maharashtra, India |
| Kims Cancer Care and Research Center Private Limited | ₹20.62 Cr (FY 2018) | •••• | •••• | -2.0% | •••• | Thiruvananthapuram, Kerala, India |
Peers are the five companies nearest above and the five nearest below Optimum Therapeutics by revenue in the Healthcare industry (Oncology Care), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Optimum Therapeutics Private Limited
Optimum Therapeutics Private Limited is audited by DHINGRA & JUNEJA for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| DHINGRA & JUNEJA | Locked | Locked | Locked |
Premium access
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Optimum Therapeutics Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Optimum Therapeutics Private Limited
Open charges
₹3.3 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Oct 2024 | Hdfc Bank Limited | ₹30 Lakh | Open |
| 14 Jan 2022 | Hdfc Bank Limited | ₹3 Cr | Open |
Total charge records: 2 View all charges
Legal Cases of Optimum Therapeutics Private Limited
Optimum Therapeutics Private Limited has 5 court cases on record: 2 filed by Optimum Therapeutics, 3 filed against it. 2 cases are pending and 3 are disposed. Status as checked between 28 Sep 2026 and 03 Oct 2026.
Total cases
5
Filed by the company
2
Filed against the company
3
Pending
2
Disposed
3
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 4 | 3 | 2 |
| High courts | 1 | 0 | 0 |
Cases on record (4 of 5)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Bulandshahr, Uttar Pradesh | Criminal case | Filed against the company by State of Uttar Pradesh | Pending |
| District court, New Delhi, Delhi | Revision petition | Filed by the company against Union of India | Pending |
| District court, Mathura, Uttar Pradesh | Criminal case | Filed against the company by State Government | Disposed |
| High Court of Delhi | Court case (CRL.M.C.) | Filed by the company against Union of India | Disposed |
Premium access
Full case history
All 5 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Optimum Therapeutics Private Limited
Employment history and EPFO contributions of people linked to Optimum Therapeutics.
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Optimum Therapeutics Private Limited
Optimum Therapeutics Private Limited has 2 board changes on record since 2011: 2 appointments. The latest: Jamal Anono Khan was appointed as Director on 13 Dec 2011.
AGM
Optimum Therapeutics Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Optimum Therapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 30.00 Lakh with Charge ID 101012979 was registered on 21 Oct 2024.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 300.00 Lakh with Charge ID 100543710 was registered on 14 Jan 2022.
Appointed
Jamal Anono Khan was appointed as Director.
Appointed
Sharmin Yaqin was appointed as Director.
Incorporation
13 Dec 2011
Optimum Therapeutics Private Limited was registered on 13 Dec 2011 with Roc Delhi & aged 14 years 10 months as per MCA records.
Credit Ratings, Litigation & Regulatory Alerts for Optimum Therapeutics Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Optimum Therapeutics Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Optimum Therapeutics Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Optimum Therapeutics Private Limited
Optimum Therapeutics has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
Total GSTINs
1
Cancelled / inactive
1
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Optimum Therapeutics Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Optimum Therapeutics Private Limited
Optimum Therapeutics is an active private limited company based in New Delhi, Delhi, India. The company works in oncology clinics and cancer treatment, within the healthcare industry. It was incorporated on 13 December 2011 (15+ years old) and is registered under CIN U85100DL2011PTC228675.
Optimum Therapeutics reported revenue of ₹23.73 Cr for FY 2024 (up 16% YoY).
Optimum Therapeutics has 2 current directors:
- Sharmin Yaqin - Director
- Jamal Anono Khan - Director
Optimum Therapeutics reported a net profit of ₹1.74 Cr (net margin 7.3%) and EBITDA of ₹3.32 Cr (EBITDA margin 14%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Optimum Therapeutics is 15% over three years and 16% over five years. In the latest year (FY 2024) revenue rose 16%. CAGR is the steady yearly rate that links the first and the last year.
No. Optimum Therapeutics has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Optimum Therapeutics is U85100DL2011PTC228675. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Optimum Therapeutics has 5 court cases on record: 2 filed by the company and 3 filed against it. 2 are pending. Most are in the district courts.
Optimum Therapeutics was incorporated on 13 December 2011, making it 15+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Optimum Therapeutics by revenue are Carcinova Private Limited, Cancer Centers of America Private Limited, Suprex Healthcare Private Limited, Buddha Cancer Centre Private Limited, Oncocare Medicals Private Limited and 5 more, all in the Healthcare industry (Oncology Care).
Jamal Anono Khan was appointed as Director on 13 Dec 2011. Sharmin Yaqin was appointed as Director on 13 Dec 2011.